LLM-Powered AI Screening Tool Accelerates Enrollment in Phase III Polycythemia Vera Trial
A medically trained large language model (LLM) system called Synapsis AI significantly reduced the time and workload required to identify eligible participants for a randomized phase III clinical trial in…
Share